Symbiotic microflora enzyme, application thereof and food prepared from symbiotic microflora enzyme

Abstract

The invention relates to the technical field of food enzymes, and discloses a symbiotic microflora enzyme. The symbiotic microflora enzyme contains symbiotic microflora which has the effect of preventing, resisting and inhibiting helicobacter pylori. The symbiotic microflora contains main microflora and auxiliary microflora which aim at enhancing microflora effects and increasing the microflora number, wherein the main microflora comprises lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus plantarum, lactobacillus rhamnosus, Roy's lactobacillus, lactobacillus casei, lactobacillus gasseri, lactobacillus johnsonii, lactobacillus salivarius, lactobacillus brevis, lactic streptococci, bacillus subtilis, bifidobacterium bifidum, bifidobacterium adolescentis, bifidobacterium infantis, bifidobacterium breve and bifidobacterium longum. After the symbiotic microflora enzyme is drunk, the contained powerful and rich symbiotic microflora can naturally exist in the digestive system of the human body, obtains the living space advantage in the ecological environment, and achieves the effect of eliminating helicobacter pylori.

Description

technical field [0001] The invention relates to the technical field of food enzymes, in particular to a symbiotic flora enzyme capable of eliminating and reducing the growth of Helicobacter pylori, its application, and food made from it. Background technique [0002] Helicobacter pylori (HP) is a spiral-shaped, Gram-negative microaerophilic bacterium. Helicobacter pylori is highly contagious and can be transmitted through hands, unclean food, feces, saliva, shared meals, raw food, etc. Helicobacter pylori cannot grow and reproduce in the atmosphere. Humans are the only natural host of Helicobacter pylori. It mainly exists in the oral cavity and gastrointestinal tract. With the help of the flagella on one side of the bacteria, it provides power to pass through the mucus layer. Possess extremely strong athletic ability, and strong power is an important reason for the pathogenicity of Helicobacter pylori. The adhesin of Helicobacter pylori makes it firmly connected to the gas...

AI Technical Summary

Problems solved by technology

At present, the method of detecting the infection of human body by Helicobacter pylori is carbon-13 breath test: the test must be carried out on an empty stomach or two hours after a meal, and the patient has not taken antibiotics, bismuth preparations, proton pump inhibitors and other helicobacter pylori in the past month Bacillus sensitive drugs, otherwise it will cause false negative test results

[0004] In the prior art, triple therapy, that is, "colloidal bismuth or proton pump inhibitors (Proton pumpinhibitors, PPIs) + two antibiotics" therapy is the most effective treatment for killing Helicobacter pylori, but this therapy is not ideal for in vivo administration , the cure rate is low, and it is easy to develop drug resistance, and the effect of complete cure cannot be achieved at present

Although the existing drug treatment methods can effectively inhibit the infection of Helicobacter pylori, there is also the problem that the human body is prone to drug resistance, resulting in no cure and lifelong infection

[0005] Traditionally prepared enzymes contain very little or no probiotics, and the enzyme content is also very small, which has very little effect on the human body, and has no effect on Helicobacter pylori.

Images